{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:22:24Z","timestamp":1791660144424,"version":"4.3.4"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In addition to preventing pneumococcal disease, emerging evidence indicates that pneumococcal conjugate vaccines (PCVs) might indirectly reduce viral respiratory tract infections (RTIs) by affecting pneumococcal-viral interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review of interventional and observational studies published during 2000\u20132022 on vaccine efficacy\/adjusted effectiveness (VE) and overall effect of PCV7, PCV9, PCV10, or PCV13 against viral RTIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixteen of 1671 records identified were included. Thirteen publications described effects of PCVs against viral RTIs in children. VE against influenza ranged between 41% and 86% (n = 4), except for the 2010\u20132011 influenza season. In a randomized controlled trial, PCV9 displayed efficacy against any viral RTI, human seasonal coronavirus, parainfluenza, and human metapneumovirus. Data in adults were limited (n = 3). PCV13 VE was 4%\u201325% against viral lower RTI, 32%\u201335% against coronavirus disease 2019 outcomes, 24%\u201351% against human seasonal coronavirus, and 13%\u201336% against influenza A lower RTI, with some 95% confidence intervals spanning zero. No protection was found against adenovirus or rhinovirus in children or adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PCVs were associated with protection against some viral RTI, with the strongest evidence for influenza in children. Limited evidence for adults was generally consistent with pediatric data. Restricting public health evaluations to confirmed pneumococcal outcomes may underestimate the full impact of PCVs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiae125","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T17:44:22Z","timestamp":1709833462000},"page":"e657-e667","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature Review"],"prefix":"10.1093","volume":"230","author":[{"given":"Ingrid T","family":"Sep\u00falveda-Pach\u00f3n","sequence":"first","affiliation":[{"name":"Epidemiology Department, P95 Epidemiology and Pharmacovigilance , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5542-0780","authenticated-orcid":false,"given":"Eileen M","family":"Dunne","sequence":"additional","affiliation":[{"name":"Global Vaccines and Antivirals, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-0211","authenticated-orcid":false,"given":"Germaine","family":"Hanquet","sequence":"additional","affiliation":[{"name":"Epidemiology Department, P95 Epidemiology and Pharmacovigilance , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-551X","authenticated-orcid":false,"given":"Marc","family":"Baay","sequence":"additional","affiliation":[{"name":"Epidemiology Department, P95 Epidemiology and Pharmacovigilance , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-1185","authenticated-orcid":false,"given":"Sonia","family":"Menon","sequence":"additional","affiliation":[{"name":"Epidemiology Department, P95 Epidemiology and Pharmacovigilance , Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-530X","authenticated-orcid":false,"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[{"name":"Global Vaccines and Antivirals, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-7194","authenticated-orcid":false,"given":"Bradford D","family":"Gessner","sequence":"additional","affiliation":[{"name":"Global Vaccines and Antivirals, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9202","authenticated-orcid":false,"given":"Christian","family":"Theilacker","sequence":"additional","affiliation":[{"name":"Global Vaccines and Antivirals, Pfizer Inc , Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"2024092316154547700_jiae125-B1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024092316154547700_jiae125-B2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jmii.2019.08.013","article-title":"Viral etiologies of acute respiratory tract infections among hospitalized children\u2014a comparison between single and multiple viral infections","volume":"52","author":"Yen","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"2024092316154547700_jiae125-B3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mib.2016.11.003","article-title":"Viral-bacterial co-infections in the respiratory tract","volume":"35","author":"Bakaletz","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"2024092316154547700_jiae125-B4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"key":"2024092316154547700_jiae125-B5","doi-asserted-by":"crossref","first-page":"100955","DOI":"10.1016\/j.eclinm.2021.100955","article-title":"Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients","volume":"37","author":"Liu","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2024092316154547700_jiae125-B6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/v13091725","article-title":"Viral and bacterial co-infections in the lungs: dangerous liaisons","volume":"13","author":"Oliva","year":"2021","journal-title":"Viruses"},{"key":"2024092316154547700_jiae125-B7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1086\/511989","article-title":"The 1918 influenza pandemic: insights for the 21st century","volume":"195","author":"Morens","year":"2007","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41590-018-0231-y","article-title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus","volume":"19","author":"Jochems","year":"2018","journal-title":"Nat Immunol"},{"key":"2024092316154547700_jiae125-B9","first-page":"e141088","article-title":"Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine","volume":"6:","author":"Carniel","year":"2021","journal-title":"JCI Insight"},{"key":"2024092316154547700_jiae125-B10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2511.190157","article-title":"Nasopharyngeal pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness","volume":"25","author":"Howard","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"2024092316154547700_jiae125-B11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm1077","article-title":"A role for Streptococcus pneumoniae in virus-associated pneumonia","volume":"10","author":"Madhi","year":"2004","journal-title":"Nat Med"},{"key":"2024092316154547700_jiae125-B12","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1093\/cid\/ciy993","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of all-cause pneumonia in adults aged \u226560 years: a population-based, retrospective cohort study","volume":"68","author":"Kolditz","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamainternmed.2022.5472","article-title":"Association of pneumococcal conjugate vaccine use with hospitalized pneumonia in Medicare beneficiaries 65 years or older with and without medical conditions, 2014 to 2017","volume":"183","author":"Kobayashi","year":"2023","journal-title":"JAMA Intern Med"},{"key":"2024092316154547700_jiae125-B14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/infdis\/jiac098","article-title":"Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case-control study","volume":"227","author":"Lewnard","year":"2023","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/14760584.2021.1889376","article-title":"The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia","volume":"20","author":"Gessner","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"2024092316154547700_jiae125-B16","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.vaccine.2013.07.006","article-title":"Vaccine effects and impact of vaccination programmes in post-licensure studies","volume":"31","author":"Hanquet","year":"2013","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1086\/503053","article-title":"Pneumococcal coinfection with human metapneumovirus","volume":"193","author":"Madhi","year":"2006","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jpeds.2008.05.060","article-title":"Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled trial","volume":"153","author":"Jansen","year":"2008","journal-title":"J Pediatr"},{"key":"2024092316154547700_jiae125-B19","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1016\/j.vaccine.2016.09.011","article-title":"Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: a case-population study","volume":"34","author":"Abadom","year":"2016","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B20","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.vaccine.2019.04.026","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age","volume":"37","author":"Karppinen","year":"2019","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B21","doi-asserted-by":"crossref","first-page":"e02347-20","DOI":"10.1128\/mBio.02347-20","article-title":"Pneumococcal conjugate vaccine protection against coronavirus-associated pneumonia hospitalization in children living with and without HIV","volume":"12:","author":"Nunes","year":"2021","journal-title":"mBio"},{"key":"2024092316154547700_jiae125-B22","doi-asserted-by":"crossref","first-page":"29256","DOI":"10.3402\/ijch.v74.29256","article-title":"Lower respiratory tract infection hospitalizations among American Indian\/Alaska Native children and the general United States child population","volume":"74","author":"Foote","year":"2015","journal-title":"Int J Circumpolar Health"},{"key":"2024092316154547700_jiae125-B23","doi-asserted-by":"crossref","first-page":"e1001776","DOI":"10.1371\/journal.pmed.1001776","article-title":"Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data","volume":"12","author":"Weinberger","year":"2015","journal-title":"PLoS Med"},{"key":"2024092316154547700_jiae125-B24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/cid\/cix923","article-title":"The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469589 births, 1996\u20132012","volume":"66","author":"Fathima","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2352-4642(20)30090-0","article-title":"Acute lower respiratory infections in Indigenous infants in Australia\u2019s Northern Territory across three eras of pneumococcal conjugate vaccine use (2006\u201315): a population-based cohort study","volume":"4","author":"Binks","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2024092316154547700_jiae125-B26","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.vaccine.2020.01.094","article-title":"Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland","volume":"38","author":"Sigurdsson","year":"2020","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B27","author":"Do"},{"key":"2024092316154547700_jiae125-B28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmi.2017.10.006","article-title":"The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: exploratory analysis of the CAPiTA trial","volume":"24","author":"Huijts","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2024092316154547700_jiae125-B29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/INF.0b013e318280a34b","article-title":"Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study","volume":"32","author":"Dominguez","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2024092316154547700_jiae125-B30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/infdis\/jiab128","article-title":"Prevention of coronavirus disease 2019 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and severe acute respiratory syndrome coronavirus 2 in the respiratory tract","volume":"225","author":"Lewnard","year":"2022","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B31","doi-asserted-by":"crossref","first-page":"ofad199","DOI":"10.1093\/ofid\/ofad199","article-title":"Pneumococcal conjugate vaccines are protective against respiratory syncytial virus hospitalizations in infants: a population-based observational study","volume":"10","author":"Le","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2024092316154547700_jiae125-B32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41479-023-00112-w","article-title":"Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection","volume":"15:","author":"Dunne","year":"2023","journal-title":"Pneumonia (Nathan)"},{"key":"2024092316154547700_jiae125-B33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/cid\/ciac907","article-title":"Association of upper respiratory Streptococcus pneumoniae colonization with severe acute respiratory syndrome coronavirus 2 infection among adults","volume":"76","author":"Parker","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/ciab1051","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against medically attended lower respiratory tract infection and pneumonia among older adults","volume":"75","author":"Lewnard","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B35","doi-asserted-by":"crossref","first-page":"e221111","DOI":"10.1001\/jamanetworkopen.2022.1111","article-title":"Incidence and estimated vaccine effectiveness against hospitalizations for all-cause pneumonia among older US adults who were vaccinated and not vaccinated with 13-valent pneumococcal conjugate vaccine","volume":"5","author":"Hsiao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024092316154547700_jiae125-B36","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1016\/j.vaccine.2018.05.097","article-title":"A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands","volume":"37","author":"Gessner","year":"2019","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B37","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/ciab375","article-title":"Expanded analysis of 20 pneumococcal serotypes associated with radiographically confirmed community-acquired pneumonia in hospitalized US adults","volume":"73","author":"Isturiz","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B38","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1016\/j.vaccine.2019.05.065","article-title":"A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands","volume":"37","author":"Gessner","year":"2019","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/infdis\/jix641","article-title":"Etiology and impact of coinfections in children hospitalized with community-acquired pneumonia","volume":"218","author":"Nolan","year":"2018","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B40","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/cix1066","article-title":"Pneumococcal community-acquired pneumonia detected by serotype-specific urinary antigen detection assays","volume":"66","author":"Wunderink","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B41","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.1093\/cid\/cix101","article-title":"The effect of antibiotic exposure and specimen volume on the detection of bacterial pathogens in children with pneumonia","volume":"64","author":"Driscoll","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40168-017-0302-6","article-title":"Influence of the pneumococcal conjugate vaccines on the temporal variation of pneumococcal carriage and the nasal microbiota in healthy infants: a longitudinal analysis of a case\u2013control study","volume":"5","author":"Mika","year":"2017","journal-title":"Microbiome"},{"key":"2024092316154547700_jiae125-B43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid2002.131220","article-title":"Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children","volume":"20","author":"Biesbroek","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2024092316154547700_jiae125-B44","doi-asserted-by":"crossref","first-page":"e157124","DOI":"10.1172\/JCI157124","article-title":"Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2","volume":"132:","author":"Mitsi","year":"2022","journal-title":"J Clin Invest"},{"key":"2024092316154547700_jiae125-B45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/cid\/cix941","article-title":"Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory tract infection","volume":"66","author":"DeMuri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024092316154547700_jiae125-B46","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2019.05.080","article-title":"Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density","volume":"37","author":"German","year":"2019","journal-title":"Vaccine"},{"key":"2024092316154547700_jiae125-B47","first-page":"1111","article-title":"Nasopharyngeal pneumococcal carriage during childhood community-acquired alveolar pneumonia: relationship between specific serotypes and coinfecting viruses","volume":"215","author":"Greenberg","year":"2017","journal-title":"J Infect Dis"},{"key":"2024092316154547700_jiae125-B48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"2024092316154547700_jiae125-B49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study","volume":"394","author":"Pneumonia Etiology Research for Child Health (PERCH) Study Group","year":"2019","journal-title":"Lancet"},{"key":"2024092316154547700_jiae125-B50"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae125\/57100552\/jiae125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/3\/e657\/59248528\/jiae125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/3\/e657\/59248528\/jiae125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:16:10Z","timestamp":1727093770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/3\/e657\/7625230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,11]]},"published-print":{"date-parts":[[2024,9,23]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae125","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9,15]]},"published":{"date-parts":[[2024,3,11]]}}}